Tech Company Financing Transactions
Primorigen Biosciences Funding Round
Primorigen Biosciences closed a $2.5 million funding round on 8/21/2006. Investors included Louisiana Fund.
Transaction Overview
Company Name
Announced On
8/21/2006
Transaction Type
Venture Equity
Amount
$2,450,000
Round
Undisclosed
Investors
Louisiana Fund (Joseph Lovett)
Proceeds Purpose
Primorigen, a developer of protein targets, quantitative microarrays, and related products, will use a pair of investments totaling $2.45 million to commercialize new cell therapy technologies that could be used to treat chronic conditions such as diabetes and Alzheimer's disease.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
510 Charmany Dr.
Madison, WI 53719
USA
Madison, WI 53719
USA
Phone
Website
Email Address
Overview
Based in the University Research Park in Madison, WI, Primorigen Biosciences LLC is focused on developing breakthrough research technologies that address unmet customer needs in the field of cell therapy development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Burke
Browse more venture capital transactions:
Prev: 8/21/2006: Bivio Networks venture capital transaction
Next: 8/21/2006: Covega venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs